Barr Pharmaceuticals, Inc.

Contact Us Product Guide Drug Information Site Map

Proprietary Business Strategies > Corporate Development

To support its business strategies, the Company continually evaluates acquisition opportunities to strengthen its product portfolio and help grow its proprietary products business. Barr regularly evaluates opportunities such as strategic product acquisitions, new technology arrangements including new technology platforms, and corporate mergers and acquisitions.

Proprietary Business Overview
Proprietary Business Strategies
•Proprietary History and Strategy
•Proprietary Product Pipeline
•Corporate Development
Key Marketed Proprietary Products
Proprietary Product Pipeline
Proprietary Sales Force
FDA Approval Process
Clinical Trials

Barr Pharmaceuticals, Inc.

Terms of Use Legal Notice Privacy Policy

Mission Corporate Profile Business Strategies Annual Report Facilities Government Affairs Barr History

Generic Business Overview Generic Business Strategies Key Generic Products Generic Product Pipeline Generic Sales Process
FAQ About Generics Generic Drug FDA Approval Process History of Generic Industry Industry Links Clinical Trials

Proprietary Business Overview Proprietary Business Strategies Key Marketed Proprietary Products
Proprietary Product Pipeline Proprietary Sales Force FDA Approval Process Clinical Trials

Corporate Profile Stock Quote Financials Fact Sheets Annual Reports 2008 Proxy Online Current Investor Presentation Analyst Coverage
Calendar of Events Audio Archives and Presentations SEC Filings Corporate Governance E-Mail Alerts Information Request

Career Opportunities Corporate Profile Mission Financials Generic Business Overview Key Generic Products
Proprietary Business Overview Key Proprietary Products Proprietary Product Sales Forces